BioHarvest Sciences Inc. (BHST)

Market Cap	98.32M -3.0%
Revenue (ttm)	32.72M +45.9%
Net Income	-11.89M
EPS	-0.68
Shares Out	22.65M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,683
Open	4.270
Previous Close	4.270
Day's Range	4.270 - 4.465
52-Week Range	4.100 - 12.800
Beta	1.38
Analysts	Strong Buy
Price Target	12.00 (+176.5%)
Earnings Date	Mar 31, 2026

About BHST

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2007
• Employees: 2
• Stock Exchange: NASDAQ
• Ticker Symbol: BHST
• Website: https://www.bioharvest.com

Financial Performance

In 2024, BioHarvest Sciences's revenue was $25.19 million, an increase of 98.77% compared to the previous year's $12.67 million. Losses were -$12.91 million, 2.78% more than in 2023.

Analyst Summary

According to 2 analysts, the average rating for BHST stock is "Strong Buy." The 12-month stock price target is $12.0, which is an increase of 176.50% from the latest price.

Price Target

$12.0

(176.50% upside)

Analyst Consensus: Strong Buy